IVERIC bio Future Growth
Future criteria checks 5/6
IVERIC bio is forecast to grow earnings and revenue by 59% and 58% per annum respectively. EPS is expected to grow by 61.5% per annum. Return on equity is forecast to be -21.7% in 3 years.
Key information
59.0%
Earnings growth rate
61.5%
EPS growth rate
Biotechs earnings growth | 28.1% |
Revenue growth rate | 58.0% |
Future return on equity | -21.7% |
Analyst coverage | Good |
Last updated | 23 Jun 2023 |
Recent future growth updates
Recent updates
Iveric drives Apellis lower as Street reacts to Phase 3 data for GA candidate
Sep 06IVERIC bio Q2 2022 Earnings Preview
Jul 25Iveric bio pay DelSiTech €1.25M upfront to develop new formulations of eye disorder drug Zimura
Jul 05IVERIC bio: A First Take
Jun 23We're Hopeful That IVERIC bio (NASDAQ:ISEE) Will Use Its Cash Wisely
May 20Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Feb 01IVERIC bio (NASDAQ:ISEE) Is In A Good Position To Deliver On Growth Plans
Nov 03Estimating The Intrinsic Value Of IVERIC bio, Inc. (NASDAQ:ISEE)
Sep 28Apellis' Loss Is Iveric Bio's Gain In Lucrative Eye Disease Field
Sep 16Here's Why We're Not Too Worried About IVERIC bio's (NASDAQ:ISEE) Cash Burn Situation
Jul 02IVERIC bio discusses GATHER2 enrollment and retention updates and new GATHER1 post-hoc analyses
Jun 18IVERIC bio EPS misses by $0.04
May 05We're Hopeful That IVERIC bio (NASDAQ:ISEE) Will Use Its Cash Wisely
Mar 12We Think IVERIC bio (NASDAQ:ISEE) Can Afford To Drive Business Growth
Nov 27IVERIC bio EPS misses by $0.05
Nov 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 365 | -28 | 57 | N/A | 9 |
12/31/2024 | 124 | -200 | -131 | -154 | 9 |
12/31/2023 | 11 | -281 | -212 | -236 | 8 |
3/31/2023 | N/A | -223 | -178 | -177 | N/A |
12/31/2022 | N/A | -185 | -165 | -164 | N/A |
9/30/2022 | N/A | -159 | -138 | -137 | N/A |
6/30/2022 | N/A | -141 | -123 | -122 | N/A |
3/31/2022 | N/A | -122 | -107 | -107 | N/A |
12/31/2021 | N/A | -115 | -99 | -99 | N/A |
9/30/2021 | N/A | -107 | -97 | -97 | N/A |
6/30/2021 | N/A | -108 | -86 | -86 | N/A |
3/31/2021 | N/A | -96 | -78 | -78 | N/A |
12/31/2020 | N/A | -85 | -66 | -66 | N/A |
9/30/2020 | N/A | -77 | -57 | -57 | N/A |
6/30/2020 | N/A | -66 | -54 | -54 | N/A |
3/31/2020 | N/A | -61 | -51 | -51 | N/A |
12/31/2019 | N/A | -59 | -48 | -48 | N/A |
9/30/2019 | N/A | 63 | -47 | -47 | N/A |
6/30/2019 | N/A | 62 | -45 | -45 | N/A |
3/31/2019 | N/A | 64 | -44 | -44 | N/A |
12/31/2018 | N/A | 63 | -42 | -42 | N/A |
9/30/2018 | N/A | -51 | -45 | -45 | N/A |
6/30/2018 | 207 | 153 | -50 | -50 | N/A |
3/31/2018 | 208 | 144 | -72 | -72 | N/A |
12/31/2017 | 210 | 114 | -122 | -122 | N/A |
9/30/2017 | 215 | 57 | -142 | -141 | N/A |
6/30/2017 | 10 | -192 | -132 | -131 | N/A |
3/31/2017 | 37 | -200 | -134 | -133 | N/A |
12/31/2016 | 51 | -193 | N/A | -109 | N/A |
9/30/2016 | 50 | -163 | N/A | -115 | N/A |
6/30/2016 | 52 | -141 | N/A | -133 | N/A |
3/31/2016 | 26 | -149 | N/A | -84 | N/A |
12/31/2015 | 52 | -106 | N/A | -79 | N/A |
9/30/2015 | 48 | -102 | N/A | -29 | N/A |
6/30/2015 | 85 | -54 | N/A | -50 | N/A |
3/31/2015 | 83 | -89 | N/A | 96 | N/A |
12/31/2014 | 41 | -117 | N/A | 111 | N/A |
9/30/2014 | 40 | -106 | N/A | 75 | N/A |
6/30/2014 | N/A | -132 | N/A | 107 | N/A |
3/31/2014 | N/A | -71 | N/A | -61 | N/A |
12/31/2013 | N/A | -57 | N/A | -49 | N/A |
9/30/2013 | N/A | -42 | N/A | -27 | N/A |
6/30/2013 | N/A | -30 | N/A | -18 | N/A |
3/31/2013 | N/A | -23 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ISEE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: ISEE is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ISEE is expected to become profitable in the next 3 years.
Revenue vs Market: ISEE's revenue (58% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: ISEE's revenue (58% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ISEE is forecast to be unprofitable in 3 years.